Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Taxes (2016 - 2020)

China Pharma Holdings' Change in Taxes history spans 11 years, with the latest figure at -$155827.0 for Q3 2020.

  • For Q3 2020, Change in Taxes fell 332.74% year-over-year to -$155827.0; the TTM value through Sep 2020 reached $113571.0, up 1315.18%, while the annual FY2019 figure was $12971.0, 108.82% up from the prior year.
  • Change in Taxes reached -$155827.0 in Q3 2020 per CPHI's latest filing, down from $227245.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $227245.0 in Q2 2020 to a low of -$163335.0 in Q1 2018.
  • Average Change in Taxes over 5 years is $4244.9, with a median of -$10350.0 recorded in 2019.
  • Peak YoY movement for Change in Taxes: crashed 711.18% in 2017, then surged 2655.49% in 2020.
  • A 5-year view of Change in Taxes shows it stood at $146187.0 in 2016, then plummeted by 88.35% to $17034.0 in 2017, then tumbled by 291.78% to -$32667.0 in 2018, then surged by 68.32% to -$10350.0 in 2019, then tumbled by 1405.57% to -$155827.0 in 2020.
  • Per Business Quant, the three most recent readings for CPHI's Change in Taxes are -$155827.0 (Q3 2020), $227245.0 (Q2 2020), and $52503.0 (Q1 2020).